http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003130503-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-22 |
| filingDate | 2002-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18ab920ed4739172b940b8c764390c4d |
| publicationDate | 2003-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003130503-A1 |
| titleOfInvention | Crystallization of 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane |
| abstract | A method is provided in which 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.0 5,9 0 3,11 ]-dodecane (CL- 20 or HNIW) is crystallized to its ε-polymorph by an inverse precipitation technique. A dry CL- 20 solvent solution containing an amount of CL- 20 dissolved in a CL- 20 solvent is prepared. The dry solvent solution is added to a crystallizer containing a CL- 20 non-solvent to cause precipitation of epsilon polymorph CL- 20 crystals by the inverse precipitation technique. The precipitated epsilon polymorph CL- 20 crystals are separated from the non-solvent and the solvent. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106188071-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105924447-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105924447-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105859730-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105859730-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104169340-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013044891-A1 |
| priorityDate | 2002-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.